The US' Food and Drug Administration, normativity of risk assessment, GMOs, and American democracy
Journal of Agricultural and Environmental Ethics 2009; 22(2): 125-139
Showing items related by title, author, creator and subject.
Recommendations for Implementation of Community Consultation and Public Disclosure Under the Food and Drug Administration's "Exception From Informed Consent Requirements for Emergency Research": A Special Report From the American Heart Association Emergency Cardiovascular Care Committee and Council on Cardiopulmonary, Perioperative and Critical Care: Endorsed by the American College of Emergency Physicians and the Society for Academic Emergency Medicine Halperin, Henry; Paradis, Norman; Mosesso, Vincent Jr.; Nichol, Graham; Sayre, Michael; Ornato, Joseph P.; Gerardi, Michael; Nadkarni, Vinay M.; Berg, Robert; Becker, Lance; Siegler, Mark; Collins, Megan; Cairns, Charles B.; Biros, Michelle H.; Vanden Hoek, Terry; Peberdy, Mary Ann (2007-10-16)
Symptom Reduction and Suicide Risk Among Patients Treated With Placebo in Antipsychotic Clinical Trials: An Analysis of the Food and Drug Administration Database Khan, Arif; Khan, Shirin R.; Leventhal, Robyn M.; Brown, Walter A. (2001-09)
A Bill to Require the Environmental Protection Agency and the Food and Drug Administration to Prepare a Comparison of Risk Prior to the Promulgation of Any Rule or Regulation. H.R. 3023, 96th Congress, 1st Session Unknown author (United States. Congress. House, 1979)